|
⚲
|
| Afferent Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001476010 |
| Sale | 2009-12-09 ($23.0 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 6175852000 |
| Address | c/o Third Rock Ventures, LP Boston, 02116 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kevin Starr | |
| David Neafus | |
| Arthur Pappas | |
| Jesse Treu | |
| Liam Ratcliffe | |
| Mitchell Bloom |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Tolleson 2024 Alternative Income, LP
✚
|
0.0 | |
|
Tolleson 2024 Private Investment, LP
✚
|
0.0 | |
|
Tollpass, LLC
✚
|
0.0 | |
|
Tomes John
✚
|
0.0 | |
|
Tompras Jennifer O.
✚
|
0.0 | |
|
Tompras Nicholas V.
✚
|
0.0 | |
|
Tonner-One World Holdings Inc
✚
|
0.0 | |
|
Topercer Benjamin James
✚
|
0.0 | |
|
TOP Invest LLC
✚
|
0.0 | |
|
Tolis Panagiotis
✚
|
0.0 |